March 14, 2012
Pharmaceutical giant Hoffmann-La Roche Inc. lost a bid Wednesday to block Apotex Inc., Mylan Inc. and other generic-drug makers from releasing a version of the osteoporosis drug Boniva after a judge ruled Roche would have difficulty withstanding challenges to two of the drug's patents.